Combined chemoradiotherapy is increasingly becoming a standard of care for the nonoperative management of a variety of solid malignancies. 联合化放疗已日益成为许多实体恶性肿瘤非手术治疗中的治疗标准。
Nomograms based on long follow-up data from chemoradiotherapy in glioblastoma multiforme can now help to predict the prognosis of the individual patient. 基于多形性胶质母细胞瘤化放疗后的长期随访资料的数据图，现在可以用于预测不同患者的预后。
